Chronic cough, persisting for more than eight weeks, poses a significant diagnostic and management challenge in clinical practice. It often leads to poor quality of life and substantial healthcare utilization. This article aims to provide a comprehensive approach to diagnosing and managing this often debilitating condition.
Chronic cough is commonly caused by asthma, gastroesophageal reflux disease (GERD), and upper airway cough syndrome (UACS). Other less common causes include chronic bronchitis, bronchiectasis, and lung cancer. The pathophysiology of chronic cough involves a complex interplay between the cough reflex pathway, inflammation, and sensory nerve hypersensitivity.
Diagnosing chronic cough requires a systematic approach, starting with a detailed history and physical examination to identify potential etiologies. Laboratory investigations, imaging studies, and pulmonary function tests can further aid in diagnosis. Empirical treatment trials for common causes such as asthma, GERD, or UACS may also be warranted. Refractory cases may require referral to a specialist for further evaluation, including bronchoscopy or esophageal pH monitoring.
Management of chronic cough should be tailored to the underlying cause. For instance, asthma-related cough may respond to inhaled corticosteroids, while GERD-related cough may improve with proton pump inhibitors. Non-pharmacological interventions, including smoking cessation and avoidance of cough triggers, are equally important. For refractory cases, novel therapies targeting neural pathways, such as gabapentin and pregabalin, may be considered.
Chronic cough is a complex clinical entity requiring a comprehensive and individualized approach to diagnosis and management. Understanding the underlying pathophysiology can guide targeted treatment strategies, improving patient outcomes and quality of life. As our knowledge of chronic cough continues to evolve, further research is needed to refine diagnostic tools and develop more effective therapies.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation